14 Annual Diabetes Technology Meeting Bethesda, Maryland, November 6–8, 2014
14th Annual Diabetes Technology Meeting Bethesda, Maryland, November 6–8, 2014 Thursday, November 6, 2014 PRE-MEETING WORKSHOPS Workshop A: Reimbursement for Diabetes Technology Panel 1: Clinical & Industry Perspective 08:00 Moderator James Scott, JD Applied Policy, Alexandria, Virginia 08:05 Guideline Driven Care Robert Vigersky, MD, Colonel, Medical Corps Walter Reed National Military Medical Center, Bethesda, Maryland 08:20 Economics of Continuous Glucose Monitoring Claudia Graham, PhD, MBA, MPH Dexcom, San Diego, California 08:35 Issues in Accurately Estimating the Cost of New Technologies: The Case of Continuous Glucose Monitors Michael O'Grady, PhD NORC/University of Chicago | O'Grady Health Policy LLC, Chevy Chase, Maryland 08:50 Trends in Reimbursement Paul Radensky, MD, JD McDermott Will & Emery LLP, Washington, DC 09:05 Q & A 09:30 Break Panel 2: Payer Perspective 09:55 Moderator John Ryan, MBA ONSET Ventures, Menlo Park, California 10:00 Medicare Reimbursement for Diabetes Technologies: Is Competitive Bidding Sustainable? James Scott, JD Applied Policy, Alexandria, Virginia 10:15 Payer Perspectives on Reimbursement for Diabetes Technology Daniel Crowe, MD, CDE Superior HealthPlan | Centene, Austin, Texas 10:30 Diabetes Benefits Albert Tzeel, MD, MHSA, FACPE Humana – North Florida, Jacksonville, Florida 10:45 Diabetes Technology from an Industry Perspective: How to Create Value in a Constrained Reimbursement Environment Peter Ehrhardt Simon-Kucher & Partners LLC, Cambridge, Massachusetts 11:00 Q & A 11:25 End of workshop/Boxed lunch provided Workshop B: Technology for Detection and Prevention of Hypoglycemia Panel 1: Clinical Diagnosis/ Analytical Diagnosis 08:00 Moderators Bruce Buckingham, MD Stanford University, Stanford, California Darrell Wilson, MD Stanford University, Stanford, California 08:05 Nocturnal Hypoglycemia: Common and Dangerous Anthony McCall, MD, PhD University of Virginia, Charlottesville, Virginia 08:20 Performance of Blood Glucose Monitors at the Low-End Guido Freckmann, MD Institute for Diabetes Technology, Ulm, Germany 08:35 Performance of Continuous Glucose Monitoring Devices at the Low-End Yogish Kudva, MD Mayo Clinic, Rochester, Minnesota 08:50 Diagnosing Hypoglycemia in Neonates Matthew Signal, PhD University of Canterbury, Christchurch, New Zealand 09:05 Q & A 09:30 Break Panel 2: Prevention/ Treatment 09:55 Moderators Guillermo Arreaza-Rubin, MD National Institute of Diabetes, Digestive and Kidney Diseases | NIH, Bethesda, Maryland Asimina Mitrakou, MD University of Athens Medical School, Athens, Greece 10:00 Hypo- and Hyperglycemia Alarms: Devices and Algorithms B. Wayne Bequette, PhD Rensselaer Polytechnic Institute, Troy, New York 10:15 The Use of Technology to Prevent Hypoglycemia Pratik Choudhary, MD, MbbD, MRCP King's College London, London, United Kingdom 10:30 Social Media Surveillance for Hypoglycemia Risk Elissa Weitzman, ScD, MSc Boston Children’s Hospital | Harvard Medical School, Boston, Massachusetts 10:45 A Review of New Glucagon Therapies W. Kenneth Ward, MD Oregon Health and Science University | Pacific Diabetes Technologies, Portland, Oregon 11:00 Q & A 11:25 End of workshop/Boxed lunch provided Workshop C: Regulatory Science; New Performance Guidances & the New Surveillance Error Grid Panel 1: New FDA Glucose Guidelines 12:25 Moderator Robert Vigersky, MD, Colonel, Medical Corps Walter Reed National Military Medical Center, Bethesda, Maryland 12:30 On-Label, Off-Label, and Clinical Laboratories Improvement Amendments William Clarke, PhD, MBA, DABCC John Hopkins School of Medicine, Baltimore, Maryland 12:45 FDA Elevation of Blood Glucose Meters: 2014 Draft Guidance Documents Katherine Serrano U.S. Food and Drug Administration, Silver Spring, Maryland 13:00 How Accurate Do We Need Blood Glucose Monitors to Be in the Hospital? Marie McDonnell, MD Boston University, Boston, Massachusetts 13:15 How Accurate Do We Need Blood Glucose Monitors to Be in the Outpatient Setting? Marc Breton, PhD University of Virginia, Charlottesville, Virginia 13:30 Q & A 13:55 Break Panel 2: The New Surveillance Error Grid 14:20 Moderator Patricia Beaston, MD, PhD U.S. Food and Drug Administration, Silver Spring, Maryland 14:25 Introduction to the Surveillance Error Grid David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE Mills-Peninsula Health Services, San Mateo, California University of California, San Francisco, San Francisco, California 14:40 FDA Perspective on the Surveillance Error Grid Courtney Lias, PhD U.S. Food and Drug Administration, Silver Spring, Maryland 14:55 Analyzing Performance Data Using the Surveillance Error Grid Boris Kovatchev, PhD University of Virginia, Charlottesville, Virginia 15:10 An Industry Perspective David Simmons, MD Bayer Diabetes Care, Whippany, New Jersey 15:25 Q & A: Panelists and Christian Wakeman 15:50 End of workshop 16:00–18:30 Poster session and inauguration of the 2014 Diabetes Technology Meeting 18:30–20:00 Posters remain on display for viewing Workshop D: Improving Adherence to Diabetes Technology Devices Panel 1: Increasing Motivation to Use Technology 12:25 Moderator Judith Fradkin, MD National Institutes of Health, Bethesda, Maryland 12:30 Improving Adherence to Self Monitoring of Blood Glucose and Continuous Glucose Monitoring Susana Patton, PhD, CDE University of Kansas, Kansas City, Kansas 12:45 Strategies to Increase Adherence to Technology Bruce Buckingham, MD Stanford University, Stanford, California 13:00 Improving Health Literacy David Kerr, MD Sansum Clinic, Santa Barbara, California 13:15 Techniques for Children to Improve Adherence to Diabetes Therapy Alan Delamater, PhD University of Miami, Miami, Florida 13:30 Q & A 13:55 Break Panel 2: Improving Human Factors to Increase Adherence 14:20 Moderator David Kerr, MD Sansum Clinic, Santa Barbara, California 14:25 Better Lancing Technology Lutz Heinemann, PhD Science & Co., Düsseldorf, Germany 14:40 Digital Medicines Naunihal Virdi, MD, MBA, FACP Proteus Digital Health, Inc., Redwood City, California 14:55 Human Factors Review Priority for Insulin Delivery Devices QuynhNhu Nguyen, MS U.S. Food and Drug Administration, Silver Spring, Maryland 15:10 Hardware to Improve Adherence William Fisher, PhD Western University, London, Canada 15:25 Q & A 15:50 End of workshop 16:00–18:30 Poster session and inauguration of the 2014 Diabetes Technology Meeting 18:30–20:00 Posters remain on display for viewing Friday, November 7, 2014 07:00 Continental Breakfast Session 1: Welcome & Keynote Presentation 08:00 Welcome/Opening Remarks David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE Mills-Peninsula Health Services, San Mateo, California University of California, San Francisco, San Francisco, California 08:05 Keynote Speaker Toward a More Physiologic Insulin Therapy Alfred Mann, MS MannKind Corporation, Valencia, California Session 2: Wearable Devices for Diabetes 08:25 Moderators Karl Friedl, PhD Physiology Associates LLC, Frederick, Maryland Dorian Liepmann, PhD University of California Berkeley, Berkeley, California 08:30 Wearable Devices and Network Platforms for Artificial Pancreas and Advanced Glucose Management Patrick Keith-Hynes, PhD University of Virginia, Charlottesville, Virginia 08:45 Google Glass for Diabetic Foot Surgery Nicholas Giovinco, DPM University of Arizona College of Medicine, Tucson, Arizona 09:00 Wearable Devices to Assess Exercise and Diet Kong Chen, PhD, MSCI National Institutes of Health, Bethesda, Maryland 09:15 Q & A 09:40 End of session/Break Session 3: Big Data for Diabetes Management 10:05 Moderators Roy Vigneulle, PhD U.S. Army, Frederick, Maryland Elissa Weitzman, ScD, MSc Boston Children’s Hospital | Harvard Medical School, Boston, Massachusetts 10:10 Diabetes Technology Society Leadership Award 10:15 Big Data Technologies and Diabetes Management: A Challenging Opportunity Riccardo Bellazzi, PhD University of Pavia, Pavia, Italy 10:30 We No Longer Live in the 1990’s: Social Media is Diabetes Technology Joyce Lee, MD, MPH University of Michigan, Ann Arbor, Michigan 10:45 Bringing Together Data from Disparate Sources for Diabetes James Maisel, MD Zydoc, Hicksville, New York 11:00 Q & A 11:25 End of session/Lunch Session 4: Performance of Cleared Blood Glucose Monitors - What is Needed? 12:25 Moderator David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE Mills-Peninsula Health Services, San Mateo, California University of California, San Francisco, San Francisco, California 12:30 Panel Discussion Alan T. Cariski, MD, JD, FACP, FACE LifeScan, Inc., Fremont, California Guido Freckmann, MD Institute for Diabetes Technology, Ulm, Germany Rolf Hinzmann, MD, PhD Roche Diagnostics GmbH, Mannheim, Germany Boris Kovatchev, PhD University of Virginia, Charlottesville, Virginia Aaron Kowalski, PhD JDRF, New York, New York Areta Kupchyk Nixon Peabody LLP, Washington, DC Courtney Lias, PhD U.S. Food and Drug Administration, Silver Spring, Maryland Markus Ott, MBA Bayer, Basel, Switzerland Riccardo Perfetti, MD, PhD Sanofi, Bridgewater, New Jersey Robert Ratner, MD, FACP, FACE American Diabetes Association, Alexandria, Virginia Steve Scott Abbott Diabetes Care, Alameda, California Robert Vigersky, MD, Colonel, Medical Corps Walter Reed National Military Medical Center, Bethesda, Maryland 13:45 Break Session 5: Controversies in Developing the Artificial Pancreas 14:10 Moderators Jeffrey Joseph, DO Thomas Jefferson University, Philadelphia, Pennsylvania Boris Kovatchev, PhD University of Virginia, Charlottesville, Virginia 14:15 Artificial Pancreas Award 14:20 Panel Discussion Ali Cinar, PhD Illinois Institute of Technology, Chicago, Illinois Claudio Cobelli, PhD University of Padova, Padova, Italy Edward Damiano, PhD Boston University, Boston, Massachusetts Eyal Dassau, PhD University of California Santa Barbara, Santa Barbara, California Roman Hovorka, PhD University of Cambridge, Cambridge, United Kingdom 16:00 Adjourn 16:00–18:30 Poster Session 18:30–20:00 Posters remain on display for viewing Saturday, November 8, 2014 07:00 Continental Breakfast Session 6: Novel Treatments & New Technology for Insulin Delivery 08:00 Moderators Gerold Grodsky, PhD University of California San Francisco, San Francisco, California Richard Williams, MD National Aeronautics and Space Administration, Fredericksburg, Virginia 08:05 Short-Action and Long Acting Insulins in the Pipeline Lutz Heinemann, PhD Science & Co., Düsseldorf, Germany 08:20 A Novel Approach to Rescue Islets in Type 1 Diabetes: The Role of Non-Immune Cells Eli Lewis, PhD Ben-Gurion University of the Negev, Beer-Sheva, Israel 08:35 Insulin Pump Therapy in Type 2 Diabetes Bruce Bode, MD, FACE Atlanta Diabetes Associates, Atlanta, Georgia 08:50 Controlled Skin Temperature to Improve Insulin Absorption Andreas Pfützner, MD, PhD Pfützner Science & Health Institute, Mainz, Germany 09:05 Using Simulation Technology to Teach Diabetes Care Management Skills and Insulin Dosing JoAnn Sperl-Hillen, MD SiMCare Health, Minneapolis, Minnesota 09:20 Q & A 09:45 End of session/Break Session 7: Is Diabetes Technology Better in the U.S. or Europe? 10:10 Moderators Timothy Bailey, MD, FACE, CPI AMCR Institute, Escondido, California John Pickup, MD, PhD King’s College London, London, United Kingdom 10:15 Diabetes Technology Society (DTS) Student Research Award 10:20 Presentation by DTS Student Research Award Winner 10:35 Panel Discussion Hans De Vries, MD Academic Medical Center, Amsterdam, Netherlands Barry Ginsberg, MD, PhD Diabetes Technology Consultants, Wyckoff, New Jersey David Kerr, MD Sansum Clinic, Santa Barbara, California David Maahs, MD University of Colorado Denver, Denver, Colorado 11:35 End of session/Lunch Session 8: Role of mHealth in Managing Diabetes 12:35 Moderator Marshall Porterfield, PhD National Aeronautics and Space Administration, Fredericksburg, Virginia 12:40 Mobile Technology, “Making” Health, and the Future of Diabetes Technology Joyce Lee, MD, MPH University of Michigan, Ann Arbor, Michigan 12:55 User Experience and Behavior Change in mHealth Interventions: Human Factors Engineering Joseph Cafazzo, PhD Centre for Global eHealth Innovation | University of Toronto, Toronto, Ontario, Canada 13:10 FDA’s Role in mHealth and Diabetes Management Beth Stephen, PhD U.S. Food and Drug Administration, Silver Spring, Maryland 13:25 Diabetes mHealth: The Last Mile Aaron Neinstein, MD University of California San Francisco, San Francisco, California 13:40 Q & A 14:05 End of session/Break Session 9: New Technology in Continuous Glucose Monitoring 14:30 Moderators Alberto Gutierrez, PhD U.S. Food and Drug Administration, Silver Spring, Maryland John Pickup, MD, PhD King’s College London, London, United Kingdom 14:35 New Technology in Continuous Glucose Monitoring Rajiv Shah, MS Medtronic, Northridge, California 14:47 New Technology in Continuous Glucose Monitoring Jacob Leach Dexcom, San Diego, California 14:59 New Glucose Sensor Technology Steve Scott Abbott Diabetes Care, Alameda, California 15:11 New Sensor Technology: Improved Performance for Higher Reliability Matthias Axel Schweitzer, MD, MBA Roche Diagnostics GmbH, Mannheim, Germany 15:23 Sensing Technology: Employing a Direct Electron Transfer Principle Shinjiro Sekimoto, MS Arkray Inc., Kyoto, Japan 15:35 Performance of an Implanted Continuous Glucose Sensor in a Multi-Site Study Mark Mortellaro, PhD Senseonics, Inc., Germantown, Maryland 15:47 Q & A Session 10: Product Demonstrations 16:15 Moderator John Pickup, MD, PhD King’s College London, London, United Kingdom 16:20 Product Demonstration: Flash Glucose Monitoring Steve Scott Abbott Diabetes Care, Alameda, California 16:35 Product Demonstration: Software to Help Patients Manage Diabetes and Behaviors Neal Kaufman, MD, MPH DPS Health | UCLA School of Medicine, Los Angeles, California 16:50 Meeting Summary 17:00 Adjourn Meeting
© Copyright 2024